Suchen und Finden
Front Cover
1
Omega-3 Fatty Acids in Brain and Neurological Health
4
Copyright Page
5
Contents
6
Preface
12
List of Contributors
14
Acknowledgments
18
1 Enhanced Longevity and Role of Omega-3 Fatty Acids
20
Introduction
20
Longevity
20
Food Restriction for Enhanced Longevity
21
Calorie Restriction for Longevity
21
Smoking and Reduced Longevity
21
Genetics, a Key Modifier of Longevity
22
Genetic Diseases and Longevity
22
Genomics
23
Environmental Factors and Longevity
23
Animal Tests and Longevity
24
Omega-3 Fatty Acids and Longevity
24
References
25
Further Reading
26
2 Molecular Gerontology: Principles and Perspectives for Interventions
28
Introduction
28
Homeostasis Versus Homeodynamics
28
Molecular Basis of Aging
29
Free Radical Theory of Aging
29
Protein Error Theory of Aging
30
From FRTA and PETA to Higher Order Theories
30
Genetics, Post-Genetics, and Epigenetics of Aging
30
Epigenetics of Aging
31
Aging Interventions
31
Gene Therapy
31
Manipulating the Milieu
33
Hormetics, Hormesis, and Hormetins
33
References
34
3 Peroxisomal Pathways, their Role in Neurodegenerative Disorders and Therapeutic Strategies
38
Peroxisomes
38
Ether Lipid Synthesis
38
a-oxidation
39
ß-oxidation
39
Peroxisomal Pathologies
42
Leukodystrophies
43
X-linked Adrenoleukodystrophy
43
Lipid and Steroid Hormone Modifications
44
Biological Markers of X-ALD
44
Therapeutic Strategies
44
Fatty Acids and Dietary Intervention
45
Hormone Replacement Therapy
46
Gene Therapy
46
Demyelination and Other Leukodystrophies
46
Conclusion
47
References
47
4 Unregulated Lipid Peroxidation in Neurological Dysfunction
50
Introduction
50
Lipid Oxidation Biomarkers for Neurological Dysfunction
51
Lipid Peroxidation Products from Linoleic Acid
51
Lipid Peroxidation Products from AA
51
Hydroxyeicosatetraenoic Acids
51
F2-Isoprostanes
52
Isofurans
52
Lipid Peroxidation Products from Docosahexaenoic Acid
53
Neuroprostanes
53
Neurofurans
53
Lipid Peroxidation-Derived Short-Chain Aldehydes
53
Lipid Peroxidation Products from Cholesterol
54
Neurological Dysfunction Associated with Lipid Peroxidation
56
Mechanisms of Free Radical Production in Neurological Disorders
57
Alzheimer’s Disease
57
Parkinson’s Disease
57
Amyotrophic Lateral Sclerosis
60
Stroke
61
Down Syndrome
61
Other Neurological Dysfunctions in Childhood
62
Therapeutic Intervention with Antioxidants for Neurological Dysfunction
62
References
63
Additional References
70
5 Obesity, Western Diet Intake, and Cognitive Impairment
76
Obesity and Cognitive Impairment
76
Western Diet Intake and Cognitive Impairment
77
Western Diet Intake and Cognitive Impairment: Underlying Neuroendocrine Mechanisms
78
Summary
80
References
80
6 Genetic Risk Factors for Diabetic Neuropathy
82
Diabetes Mellitus and Its Complications
82
Diabetic Neuropathy: General Characteristics
82
Risk Factors for Diabetic Neuropathy and pathophysiological Mechanisms
82
Genetic Risk Factors for Diabetic Neuropathy
83
Potential Use of Genetic Risk Factors in Clinical Practice
85
References
86
7 n-3 Fatty Acid-Derived Lipid Mediators against Neurological Oxidative Stress and Neuroinflammation
88
Overview
88
DHA in the Brain
89
EPA-Derived Lipid Mediators in the Brain
90
DHA-derived Lipid Mediators in the Brain
92
DHA-derived D-series Resolvins
92
DHA-derived Protectins and Neuroprotectins
92
Effect of EPA and DHA in Neurological Disorders
95
Conclusion
97
References
97
8 The Impact of Omega-3 Fatty Acids on Quality of Life
100
Introduction
100
Assessment of QoL
100
Current Evidence on Omega-3 Fatty Acids and QoL
101
Evidence from Observational Studies
101
Evidence from Clinical Trials
102
Discussion
102
Conclusion and Recommendations
103
References
103
9 Mammalian Fatty Acid Amides of the Brain and CNS
106
Introduction
106
Primary Fatty Acid Amides
106
N-Acylethanolamines (NAEs)
109
N-Acyl Amino Acids (NAAs)
112
NAGs, a Specific Class of the NAAs
113
N-Acyl Taurines, a Specific Class of the NAAs
116
Other N-Acyl Amino Acids
117
N-Acyldopamines
118
The Relevance of the Fatty Acid Amides to Neurological Disease
118
Acknowledgements
121
References
121
10 Low Omega-3 Fatty Acids Diet and the Impact on the Development of Visual Connections and Critical Periods of Plasticity
128
Introduction
128
Nutrition and the Impact of Omega-3 Fatty Acids on Brain Development
128
The Development of Visual Topographical Maps
131
Critical Periods for Brain Development
132
Role of Omega-3 on Development of Central Visual Connections
133
References
136
11 The Effects of Omega-3 Polyunsaturated Fatty Acids on Maternal and Child Mental Health
140
Introduction
140
The Role of Omega-3 Fatty Acids in Neurotransmission
140
DHA and Maternal Mental Health
141
Postpartum Depression
141
Omega-3 Fatty Acids in Postpartum Depression
142
Omega-3 Fatty Acids and Child Mental Health
142
Neurodevelopmental Outcomes: Infancy through Childhood
142
Infancy
142
Childhood
143
Childhood Developmental Disorders
143
Attention Deficit Hyperactivity Disorder
144
Childhood Depression
144
Autistic Spectrum Disorders
145
Conclusion
145
References
146
12 Pain as Modified by Polyunsaturated Fatty Acids
150
Introduction
150
Factors Involved in the Supply and Physiological Function of Fatty Acids in the Brain
151
Blood–Brain Barrier
151
Fatty Acid Transporter Protein
152
Fatty Acid Binding Protein
152
Long-Chain Fatty Acid Receptor GPR40
153
Toll Like Receptor 4
153
Involvement of Lipids, Fatty Acids, and Their Metabolites in Pain Regulation
153
Dietary Lipids
153
Omega-3 Fatty Acids
154
DHA
154
Metabolites Derived from Omega-3 Fatty Acids
155
Omega-6 Fatty Acids and Their Metabolites
157
Prostaglandins
157
Leukotrienes
159
Platelet-Activating Factor
159
Lysophosphatidic Acid
160
Future Prospects
160
References
161
13 Fish Oil Supplementation Prevents Age-Related Memory Decline: Involvement of Nuclear Hormone Receptors
166
Introduction
166
Effects of Aging on Incorporation of Docosahexaenoic Acid in Brain Phospholipids
166
Effects of Aging on DHA Biosynthesis
167
DHA is Involved in Learning and Memory
168
Dietary Fish Oil and Prevention of Age-Related Memory Decline
169
Animal Studies
169
Human Studies
171
DHA Improves Synaptic Plasticity During Aging: Involvement of Retinoid X Receptors and Peroxisome Proliferator-Activated Re...
172
Summary and Concluding Remarks
174
References
176
14 Role of Omega-3 Fatty Acids in Brain and Neurological Health with Special Reference to Clinical Depression
182
Introduction
182
Omega-3 Fatty Acids
182
Factors that Interfere with Conversion of ALA
183
Omega-3 to Omega-6 Ratio
183
Genetic Factors
184
Dietary and Lifestyle Factors
184
Saturated fat – trans-fat
184
Caffeine, Nicotine, Alcohol, Sugar
184
Stress
184
Co-nutrients
184
Status of Omega-3 Fatty Acids in Clinical Depression
184
Nutrient Co-Factor Deficiencies
185
Zinc Deficiency
185
Selenium Deficiency
185
Folic Acid Deficiency
185
Antioxidants
185
Vitamin B6, Tryptophan, and Serotonin
186
Omega-3 Fatty Acids
186
Neurological Alterations in Depression
186
Possible Mechanisms for Links Between Omega-3 Fatty Acids and Depression
188
Omega-3 Fatty Acids Affect Cell Membrane Integrity and Fluidity
188
Omega-3 Fatty Acids Decrease the Production of Pro-Inflammatory Cytokines
189
Omega-3 Fatty Acids and Hippocampal Neurogenesis
189
Impact of Diet on AHN
189
Clinical Trials Supporting the Role of Omega-3 Fatty Acids in MDD
190
Conversion of ALA to EPA and DHA from Flax Seed Oil
192
Probable Mode of Action of Flax Seed Oil in Depression
192
Conclusion
194
References
195
Further Reading
198
15 Omega-3 Fatty Acid Supplementation for Major Depression with Chronic Disease
200
Introduction
200
Omega-3 Fatty Acids
200
Major Depressive Disorder
201
Omega-3 Fatty Acids and Depression
201
Effects of Omega-3 Fatty Acids on Depression with Cardiovascular Disorders
202
Effects of Omega-3 Fatty Acids on Depression with Diabetes
202
Effects of Omega-3 Fatty Acids on Depression and Pregnancy
203
Effects of Omega-3 Fatty Acids on Depression and Old Age
203
Effect of Omega-3 Fatty Acids on Anxiety and Depression in Students
203
Summary
204
References
204
16 The Effectiveness of Fish Oil as a Treatment for ADHD
206
A review of the Literature
206
Purpose
207
Analyzing the Studies
207
Findings
207
The Effect of Fish Oil on the Behavioral/Physical Symptoms of ADHD
209
Omega 3
209
Omega-3 and Omega-6
210
Combination of Essential Fatty Acids and other Supplements
211
Fatty Acid Levels in Blood of Patients with ADHD
212
Omega 3
212
No Supplements were Given
212
Conclusion
212
Final Thought
217
References
217
Further Reading
218
17 Fatty Acids and the Aging Brain
220
Introduction
220
Physiologic Brain Aging
221
Structural Changes
221
Macro-Structural Changes
221
Micro-Structural Changes
222
Chemical Changes
222
Dopamine
222
Serotonin
222
Glutamate
223
Cognitive Changes
223
Changes in Attention
223
Changes in Memory
223
Changes in Orientation
224
Changes in Perception
224
Changes in Executive Control
224
Fatty Acids and Brain Aging
224
Fatty Acid Basics: An Introduction to the Biochemistry of Fatty Acids
224
Fatty Acid Composition of the Brain
225
Omega Fatty Acids
225
Function of Omega-3 Fatty Acids in the Brain
225
Neural Mechanisms
225
Neurogenesis
225
Neurotransmission
226
Reduction of Amyloid-ß Production
226
Increasing Brain-Derived Neurotrophic Factor
226
Vascular Mechanisms
226
Reduction of Inflammation
226
Lowering of Thrombosis
226
Blood Pressure Reduction
227
Lowering Triglyceride Levels
227
Sources of Omega Fatty Acids
227
Omega Fatty Acid Metabolism
227
Pathological Brain Aging
228
Alzheimer’s Disease
228
Disease Characteristics
228
Structural Differences from Normal Aging
228
Chemical Differences
229
Cognitive Differences
229
Disease Mechanisms
229
Vascular Dementia
230
Disease Characteristics
230
Structural Changes
230
Cognitive Changes
230
Chemical Changes
230
Disease Mechanisms
230
Mixed Dementia
230
Protective Effect of Omega-3 Fatty Acids against Dementia
231
Conclusion
232
References
232
Further Reading
238
18 Cerebrovascular Changes: The Role of Fat and Obesity
240
Introduction
240
Vascularization of the Brain
240
The Blood–Brain Barrier
241
Effects of a High Fat Diet and Obesity on Overall Health and Proposed Mechanisms
241
Clinical Studies: Vascular Changes Due to a High Fat Diet and Obesity
242
Animal Studies: Vascular Changes Due to a High Fat Diet and Obesity
243
Impact of Omega-3 Fatty Acids on Vascular Health
245
Conclusion
245
References
246
19 Effects of Omega-3 Fatty Acids on Alzheimer’s Disease
250
Introduction
250
Omega-3 Fatty Acids Biology in Health
250
Alzheimer’s Disease
250
Omega-3 Fatty Acid: a Role in Alzheimer’s Disease?
251
DHA Deficiency and Neurological Function Affected by Diabetes in Alzheimer’s Disease
251
Animal Models, Diabetes, and Alzheimer’s Disease
252
Omega-3 Fatty Acids in Prevention and Treatment of Alzheimer’s Disease
253
References
254
20 Substantia Nigra Modulation by Essential Fatty Acids
256
Importance of Essential Fatty Acids as Neuroprotectors During Brain Development and Aging
256
Substantia Nigra Vulnerability to Neurodegeneration
257
Substantia Nigra Dopamine Cell Populations Display Differential Vulnerability to Lesions
258
Repercussion of EFA Deficiency or Supplementation on Midbrain Dopaminergic Systems
259
Potential Mechanisms Involved in Substantia Nigra Dopamine Cell Loss Induced by EFA Dietary Restriction
260
Acknowledgments
264
References
264
Further Reading
268
21 The Role of Omega-3 Fatty Acids in Hippocampal Neurogenesis
270
Introduction
270
Adult Neurogenesis
271
Measurement of Neurogenesis (Markers of Proliferation)
271
Omega-3 PUFAs and Hippocampal Neurogenesis
272
Developmental Neurogenesis
272
Adult Hippocampal Neurogenesis
273
Mechanisms of Action
273
References
278
22 Imaging Brain DHA Metabolism in Vivo, in Animals, and Humans
284
Introduction
284
Quantitative Imaging of Brain DHA Metabolism in Rodents
284
Incorporation of Circulating PUFAs into Brain Membrane Lipids
284
Methods and models for determining PUFA incorporation into brain
286
Imaging Membrane Synthesis
287
Neuroplasticity with Ocular Enucleation
287
Brain Tumor Imaging
287
Upregulated DHA and AA Releasing Enzymes in an Animal Model of the Metabolic Syndrome
288
Neurotransmission
288
Human Mutations and Mouse Knockouts of iPLA2ß
289
Quantitative Imaging of Brain DHA Metabolism in Human Subjects
290
Baseline Brain DHA Incorporation
290
Upregulated Incorporation Coefficients in Chronic Alcoholics
290
Summary and Conclusions
291
Acknowledgments
292
References
292
23 Obesity and Migraine in Children
296
Introduction
296
Epidemiological Relationship Between Migraine and Obesity
296
Comorbidity
297
Cognitive Profile, Migraine, and Obesity
298
Proposed Mechanism for the Relationship Between Obesity and Migraine
298
Lifestyle Factors
299
Influence of Weight Loss on Chronic Headache in Obese People and Effects of the Preventive Treatment of Migraine on Weight ...
300
Conclusions
302
References
302
24 Dietary Omega-3 Sources during Pregnancy and the Developing Brain: Lessons from Studies in Rats
306
Introduction
306
ALA Supplementation and Brain Fatty Acid Composition
307
Long-chain Omega-3 PUFA Supplementation and Brain Fatty Acid Composition
310
Direct Comparison of ALA and Long-chain Omega-3 PUFA Supplementation on Brain Fatty Acid Composition
316
Conclusions
316
References
320
25 Omega-3 Fatty Acids and Cognitive Behavior
322
Introduction
322
Infants and Children
322
Maternal Supplementation
323
Supplementation During Infancy
326
Supplementation During Childhood
328
Young Adults
330
Older Adults
333
Epidemiological Studies: The Association Between Omega-3 PUFA Intake, Omega-3 PUFA Levels, and Cognitive Decline
333
RCTs: Healthy Older Adults
338
RCTs: Older Adults with Mild Cognitive Impairment or Alzheimer’s Disease
338
Conclusion
341
References
341
26 Lipids and Lipid Signaling in Drosophila Models of Neurodegenerative Diseases
346
Introduction
346
Drosophila as a Model System of Neurodegenerative Diseases
346
Genetic Tools for Making Neurodegenerative Disease Models in Drosophila
346
P-Element-Mediated Mutagenesis
346
UAS-GAL4-Based Gene Expression System
347
Reporters for Amyloid Precursor Protein .-secretase Activity in Drosophila
348
Representative Drosophila Models for Neurodegenerative Diseases
348
Effects of Lipids and Lipid Signaling on Drosophila Models of Neurodegenerative Diseases
349
Effects of PUFA and Cholesterol Levels on Drosophila AD Models Expressing Human Aß42
349
Effect of Phosphatidylethanolamine Depletion on .-secretase-Mediated APP Processing in Transgenic Drosophila
351
Effects of Lipid Signaling Enzyme Diacylglycerol Kinase e Inhibition on Mutant Huntingtin Toxicity
351
Drosophila Mutant of Very Long-Chain Acyl Coenzyme a Synthetase and Glyceryl Trioleate Oil
351
Lipids, TRP Channels, and Neurodegeneration in Drosophila
352
Points to Consider When Drosophila Models are Used for Studying the Role of Lipids
353
Perspective
353
References
354
27 Polyunsaturated Fatty Acids in Relation to Sleep Quality and Depression in Obstructive Sleep Apnea Hypopnea Syndrome
356
Introduction
356
OSAHS
356
Sleepiness
357
OSAHS and Associated Complications
357
Polyunsaturated Fatty Acids
357
PUFAs and Health
358
Depression
359
Link Between PUFAs and Depression in OSAHS
359
Sleep Quality
361
Link Between PUFAs and Sleep Quality in OSAHS
361
Conclusion
364
References
364
Further Reading
366
28 Omega-3 Fatty Acids in Intellectual Disability, Schizophrenia, Depression, Autism, and Attention-Deficit Hyperactivity D...
368
Introduction
368
Background
368
Plasma Lipids in Adults with Intellectual Disability and the Efficacy of Omega-3 Fatty Acids
369
Adrenoleukodystrophy and Adrenomyeloneuropathy
369
Fatty Acid, Lipid, and Cholesterol Levels
370
Plasma Lipids in Schizophrenia and the Efficacy of Omega-3 Fatty Acids
371
Plasma Lipids in Depressive Illness and Efficacy of Omega-3 Fatty Acids
372
Plasma Lipids in Autism and Efficacy of Omega-3 Fatty Acids
373
Plasma Lipids in ADHD and Efficacy of Omega-3 Fatty Acids
374
Conclusions
374
References
375
29 Effect of Omega-3 Fatty Acids on Aggression
378
Introduction
378
First Trial of Omega-3 PUFAs and Aggression in Young Adults
378
Effect of Omega-3 PUFAs on Aggression in Schoolchildren
379
Effect of Omega-3 PUFAs on Aggression in the Elderly
379
Effect of Omega-3 PUFAs on Aggression in Prisoners
380
Effect of Omega-3 PUFAs on Aggression in Patients with ADHD
380
Association Between Omega-3 PUFAs and Hostility in Patients with Schizophrenia
380
Mechanism of Action of Omega-3 PUFAs
380
Serotonin
380
Noradrenalin
381
Cortical-Hippocampal-Amygdala Pathway
381
Endocannabinoids
381
Brain-Derived Neurotrophic Factor
381
Conclusion
381
References
383
30 Multiple Sclerosis: Modification by Fish Oil
386
Introduction
386
Overview
386
Cellular Level of Multiple Sclerosis
387
Omega-3 Supplementation of MS Patients
388
Varying Results Amongst Researchers
388
Summary
389
Acknowledgement
390
References
390
31 Deuterium Protection of Polyunsaturated Fatty Acids against Lipid Peroxidation: A Novel Approach to Mitigating Mitochond...
392
Introduction
392
PUFAs in Mitochondrial Membranes and Oxidative Stress
392
Mitochondrial Dysfunction, Oxidative Stress, and PD
394
Isotope Protection of PUFAS Against autoxidation
395
Yeast Models Confirm the Non-Linear Protective Effect of D-PUFAs in vivo
397
Isotope Reinforcement of PUFA in Pre-Clinical PD Modeling
397
Pre-Clinical Efficacy
399
Conclusion
399
References
400
32 Obesity, Cognitive Functioning, and Dementia: A Lifespan Prospective
404
Introduction
404
Weight-Related Variables and Dementia
404
Prospective Studies with a Focus on Dementia
406
Prospective Studies Focusing on Cognitive Functioning
407
Weight and Cognitive Function: Role of CVD Factors
408
Interactions of Obesity and CVD Risk Factors
409
Controls and Potential Mediators
409
Initial Summary
410
MetS
410
Mechanisms: General
411
Early Influences on Relations between Obesity and Cognition
412
Morbid Obesity and Clinically Important Cognitive Deficit
413
Treatment of Overweight and Obesity
414
Treatment of Obesity with Omega-3 Fatty Acids
415
Omega-3 Fatty Acid Mechanisms for Reducing Weight Loss
416
Methodologies: General Issues
416
Measurement of Cognitive Function
416
Diagnosis of Dementia
417
Formal Definitions of Mild Cognitive Impairment
417
Prospective Designs
417
Neuroimaging Studies
417
Trials
417
Final Summary and Conclusions
417
References
418
33 Dairy Products and Cognitive Functions
422
Introduction
422
Review of the Literature
422
Early Cross-Sectional and Prospective Research Findings in Associations between Dairy and Cognition
424
Cross-Sectional Studies
424
Prospective Studies
424
Summary of These Study Findings
424
Focused Dairy–Cognition Studies
428
Cross-Sectional Studies
428
Randomized Controlled Trials
429
Discussion
429
Limitations of this Literature
429
Assessment of Cognitive Functioning
430
Control of Confounding Variables
430
Dietary Assessment
430
Mechanisms of Action
430
Epidemiological and Clinical Significance
431
Summary
432
Directions for Future Research
432
References
432
34 Obesity and Chronic Low Back Pain: A Kinematic Approach
436
Introduction
436
Quantitative Movement Analysis
437
Equipment
437
Obesity and LBP: Our Experience
438
Gait Analysis
438
Trunk Movement
440
Quantification of Functional Limitation
440
Quantification of the Effects of Osteopathic Manipulative Treatment
443
Conclusions
444
References
444
Further Reading
446
35 Fatty Acids and the Hippocampus
448
Introduction
448
Fatty Acids and Memory/Hippocampus
448
SFAs, Memory, and the Hippocampus – Evidence from Animal Models
448
Neurological Impact of Saturated Fat Consumption
449
BDNF
449
Oxidative Stress
449
Neuroinflammation
450
SFAs, Memory, and the Hippocampus – Human Data
450
Omega-3 Fatty Acids, Memory, and the Hippocampus – Evidence from Animal Studies
451
Can Omega-3 Fatty Acids Remediate Damage to the Hippocampus in Humans?
452
Omega-3 Fatty Acids and Depression
452
Omega-3 Fatty Acids and their Effect on Memory and Cognition
453
Conclusion on Human Data
453
General Conclusion: Fatty Acids and their Impact on the Hippocampus
454
Fatty Acids and AD
454
SFAs and Risk of AD
454
Putative Causal Basis for Link between SFAs and AD
454
Omega-3 Fatty Acids, Cognitive Decline, and Dementia
455
Global Prevalence
455
Matched Group Studies
455
Longitudinal Studies of Cognitive Decline
456
Cognitive Decline and Self-Report Measures of Dietary Intake
456
Dementia Diagnosis and Self-Report Measures of Dietary Intake
456
Cognitive Decline and Plasma Lipid Estimates
457
Dementia Diagnosis and Plasma Lipid Estimates
457
Prevention and Treatment Studies
457
Human Data – Conclusions
458
Omega-3 Fatty Acids, AD, and Memory Impairment – Evidence from Animal Models
458
General Discussion
459
References
460
Further Reading
464
36 Fish Oil Supplements, Contaminants, and Excessive Doses
466
Introduction
466
Mercury
466
Lead
468
Selenium
468
Arsenic
469
Cadmium
470
PCBs
470
Dichlorodiphenyltrichloroethane
471
Dieldrin
471
Conclusion
472
Acknowledgment
472
References
472
37 Introduction to Fish Oil Oxidation, Oxidation Prevention, and Oxidation Correction
474
Introduction
474
Oxidation Process
474
Oxidation Indicators
474
Prevention of Oxidation and Oxidative Stability
476
Oxidation Correction
477
Summary
478
References
478
Further Reading
479
Index
480
Alle Preise verstehen sich inklusive der gesetzlichen MwSt.